These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 19955704)

  • 1. Effects of gamma-secretase inhibition on the amyloid beta isoform pattern in a mouse model of Alzheimer's disease.
    Portelius E; Zhang B; Gustavsson MK; Brinkmalm G; Westman-Brinkmalm A; Zetterberg H; Lee VM; Trojanowski JQ; Blennow K
    Neurodegener Dis; 2009; 6(5-6):258-62. PubMed ID: 19955704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.
    Portelius E; Brinkmalm G; Tran AJ; Zetterberg H; Westman-Brinkmalm A; Blennow K
    Neurodegener Dis; 2009; 6(3):87-94. PubMed ID: 19229112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pathway for amyloid precursor protein processing.
    Portelius E; Price E; Brinkmalm G; Stiteler M; Olsson M; Persson R; Westman-Brinkmalm A; Zetterberg H; Simon AJ; Blennow K
    Neurobiol Aging; 2011 Jun; 32(6):1090-8. PubMed ID: 19604603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. γ-Secretase processing and effects of γ-secretase inhibitors and modulators on long Aβ peptides in cells.
    Ran Y; Cruz PE; Ladd TB; Fauq AH; Jung JI; Matthews J; Felsenstein KM; Golde TE
    J Biol Chem; 2014 Feb; 289(6):3276-87. PubMed ID: 24352661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.
    Kounnas MZ; Danks AM; Cheng S; Tyree C; Ackerman E; Zhang X; Ahn K; Nguyen P; Comer D; Mao L; Yu C; Pleynet D; Digregorio PJ; Velicelebi G; Stauderman KA; Comer WT; Mobley WC; Li YM; Sisodia SS; Tanzi RE; Wagner SL
    Neuron; 2010 Sep; 67(5):769-80. PubMed ID: 20826309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain pyroglutamate amyloid-β is produced by cathepsin B and is reduced by the cysteine protease inhibitor E64d, representing a potential Alzheimer's disease therapeutic.
    Hook G; Yu J; Toneff T; Kindy M; Hook V
    J Alzheimers Dis; 2014; 41(1):129-49. PubMed ID: 24595198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amyloid-β isoform pattern in cerebrospinal fluid in familial PSEN1 M139T- and L286P-associated Alzheimer's disease.
    Portelius E; Fortea J; Molinuevo JL; Gustavsson MK; Andreasson U; Sanchez-Valle R
    Mol Med Rep; 2012 Apr; 5(4):1111-5. PubMed ID: 22307680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Alzheimer's Disease γ-Secretase Generates Higher 42:40 Ratios for β-Amyloid Than for p3 Peptides.
    Siegel G; Gerber H; Koch P; Bruestle O; Fraering PC; Rajendran L
    Cell Rep; 2017 Jun; 19(10):1967-1976. PubMed ID: 28591569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase.
    Qi-Takahara Y; Morishima-Kawashima M; Tanimura Y; Dolios G; Hirotani N; Horikoshi Y; Kametani F; Maeda M; Saido TC; Wang R; Ihara Y
    J Neurosci; 2005 Jan; 25(2):436-45. PubMed ID: 15647487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient.
    Portelius E; Gustavsson MK; Zetterberg H; Andreasson U; Blennow K
    Neurodegener Dis; 2012; 10(1-4):138-40. PubMed ID: 22302034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.
    Xiong H; Callaghan D; Wodzinska J; Xu J; Premyslova M; Liu QY; Connelly J; Zhang W
    Neurosci Bull; 2011 Aug; 27(4):221-32. PubMed ID: 21788993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct secretases, a cysteine protease and a serine protease, generate the C termini of amyloid beta-proteins Abeta1-40 and Abeta1-42, respectively.
    Figueiredo-Pereira ME; Efthimiopoulos S; Tezapsidis N; Buku A; Ghiso J; Mehta P; Robakis NK
    J Neurochem; 1999 Apr; 72(4):1417-22. PubMed ID: 10098844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.
    Wiltfang J; Esselmann H; Cupers P; Neumann M; Kretzschmar H; Beyermann M; Schleuder D; Jahn H; Rüther E; Kornhuber J; Annaert W; De Strooper B; Saftig P
    J Biol Chem; 2001 Nov; 276(46):42645-57. PubMed ID: 11526104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BIIB042, a novel γ-secretase modulator, reduces amyloidogenic Aβ isoforms in primates and rodents and plaque pathology in a mouse model of Alzheimer's disease.
    Scannevin RH; Chollate S; Brennan MS; Snodgrass-Belt PA; Peng H; Xu L; Jung MY; Bussiere T; Arastu MF; Talreja T; Xin Z; Dunstan RW; Fahrer D; Rohde E; Dunah AW; Wang J; Kumaravel G; Taveras AG; Moore Arnold H; Rhodes KJ
    Neuropharmacology; 2016 Apr; 103():57-68. PubMed ID: 26690893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain.
    Dovey HF; John V; Anderson JP; Chen LZ; de Saint Andrieu P; Fang LY; Freedman SB; Folmer B; Goldbach E; Holsztynska EJ; Hu KL; Johnson-Wood KL; Kennedy SL; Kholodenko D; Knops JE; Latimer LH; Lee M; Liao Z; Lieberburg IM; Motter RN; Mutter LC; Nietz J; Quinn KP; Sacchi KL; Seubert PA; Shopp GM; Thorsett ED; Tung JS; Wu J; Yang S; Yin CT; Schenk DB; May PC; Altstiel LD; Bender MH; Boggs LN; Britton TC; Clemens JC; Czilli DL; Dieckman-McGinty DK; Droste JJ; Fuson KS; Gitter BD; Hyslop PA; Johnstone EM; Li WY; Little SP; Mabry TE; Miller FD; Audia JE
    J Neurochem; 2001 Jan; 76(1):173-81. PubMed ID: 11145990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial Alzheimer disease-linked presenilin 1 variants enhance production of both Abeta 1-40 and Abeta 1-42 peptides that are only partially sensitive to a potent aspartyl protease transition state inhibitor of "gamma-secretase".
    Ikeuchi T; Dolios G; Kim SH; Wang R; Sisodia SS
    J Biol Chem; 2003 Feb; 278(9):7010-8. PubMed ID: 12493731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of the cathepsin B gene improves memory deficits in a transgenic ALZHeimer's disease mouse model expressing AβPP containing the wild-type β-secretase site sequence.
    Kindy MS; Yu J; Zhu H; El-Amouri SS; Hook V; Hook GR
    J Alzheimers Dis; 2012; 29(4):827-40. PubMed ID: 22337825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.